Jefferies Cuts Price Target on Pepsi (PEP) to $122; Reiterates Buy
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Forward Air (FWRD) Appoints Shawn Stewart as CEO
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
BMO Capital Reiterates Outperform on Pepsi (PEP) Following Solid 3Q
September 30, 2016 11:35 AM EDTBMO Capital reiterated an Outperform rating on Pepsico (NYSE: PEP), and raised the price target to $120.00 (from $116.00), following the company's 3Q earnings report. PEP exceeded or met consensus estimates for the 27th consecutive quarter. EPS was driven by solid organic sales growth, modest EBIT... More
Dunkin' partners with Coca-Cola on bottled coffee
September 29, 2016 12:49 PM EDT(Reuters) - Dunkin' Brands Group Inc (NASDAQ: DNKN) said on Thursday its doughnut chain will partner with Coca-Cola Co (NYSE: KO) to launch a line of bottled coffee beverages in the United States, its first foray into the ready-to-drink coffee market dominated by rival Starbucks Corp (NASDAQ: SBUX).
The Dunkin' Donuts chain operator said the beverages, set to launch in early 2017,... More
Pepsi (PEP) volatility decreases as shares rally on Q3 and raised guidance
September 29, 2016 12:20 PM EDTPepsi (NYSE: PEP) is recently up $1.17 to $108.55 after reporting better than expected Q3 revenue and earnings and raising its FY16 core constant currency EPS growth guidance to up 10% from up 9%. September weekly call option implied volatility is at 16, October is at 13; compared to its 52-week range of 11 to 22.
... MoreStreetinsider.com's Hot Lunchtime Reads 9/29: (VRX) (AGN) (PEP) (ARRS) (IBM)
September 29, 2016 12:16 PM EDTThe following is a list of notable articles to help get you through the lunch hour:Valeant Pharma (VRX), Other Pharma Stocks Weaker as Clinton Op-Ed Discusses Measures on Drug Prices ->... More
Pepsi (PEP) volatility comes in as shares rally on Q3 and raised guidance
September 29, 2016 12:13 PM EDTPepsi (NYSE: PEP) is recently up $1.17 to $108.55 after reporting better than expected Q3 revenue and earnings and raising its FY16 core constant currency EPS growth guidance to up 10% from up 9%. September weekly call option implied volatility is at 16, October is at 13; compared to its 52-week range of 11 to 22.
... MorePre-Open Stock Movers 09/29: (AEGR) (ARWR) (EBAY) Higher; (ITCI) (ADHD) (FIT) Lower (more...)
September 29, 2016 8:52 AM EDTToday's After-Hours Movers
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) 63.2% LOWER; announced top-line results from the second Phase 3 clinical trial (Study 302) of ITI-007, an oral, first-in-class investigational medicine for the treatment of schizophrenia. In this trial, neither dose of ITI-007 separated from placebo on the primary endpoint, change from baseline on the Positive and Negative Syndrome Scale (PANSS) total score, in the pre-defined patient population. The active control, risperidone, did separate from placebo. In this trial, ITI-007 was statistically significantly better than risperidone on key safety and tolerability parameters... More
Pepsi (PEP) Tops Q3 EPS by 8c
September 29, 2016 6:31 AM EDTPepsi (NYSE: PEP) reported Q3 EPS of $1.40, $0.08 better than the analyst estimate of $1.32. Revenue for the quarter came in at $16 billion versus the consensus estimate of $15.83 billion.
GUIDANCE:
Pepsi sees FY2016 EPS of $4.78, versus the consensus of... More
Trading Radar for 9/29: Pepsi (PEP), Accenture (ACN), Costco (COST), ConAgra (CAG) Report
September 28, 2016 2:40 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
PepsiCo (PEP) September weekly implied volatility increases into Q3 and outlook
September 28, 2016 12:24 PM EDTPepsi (NYSE: PEP) September weekly call option implied volatility is at 28, October is at 14; compared to its 52-week range of 11 to 22 into the expected release of Q3 results on September 29.
... More